Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to 0.92.

  • Veracyte's Equity Ratio fell 31.23% to 0.92 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.92, marking a year-over-year decrease of 31.23%. This contributed to the annual value of 0.9 for FY2024, which is 340.94% down from last year.
  • Veracyte's Equity Ratio amounted to 0.92 in Q3 2025, which was down 31.23% from 0.91 recorded in Q2 2025.
  • In the past 5 years, Veracyte's Equity Ratio registered a high of 0.95 during Q1 2021, and its lowest value of 0.9 during Q4 2024.
  • Its 5-year average for Equity Ratio is 0.93, with a median of 0.93 in 2022.
  • As far as peak fluctuations go, Veracyte's Equity Ratio skyrocketed by 1016.16% in 2021, and later plummeted by 340.94% in 2024.
  • Over the past 5 years, Veracyte's Equity Ratio (Quarter) stood at 0.92 in 2021, then rose by 0.72% to 0.93 in 2022, then grew by 0.72% to 0.94 in 2023, then fell by 3.41% to 0.9 in 2024, then rose by 1.65% to 0.92 in 2025.
  • Its last three reported values are 0.92 in Q3 2025, 0.91 for Q2 2025, and 0.91 during Q1 2025.